Four day inhibition of prolyl oligopeptidase causes significant changes in the peptidome of rat brain, liver and kidney

Biochimie

Volumn 94, Issue 9, 2012, Pages 1849-1859

  Tenorio Laranga, Jofre ^a   Männistö, Pekka T ^a   Storvik, Markus ^b   Van Der Veken, Pieter ^c   García Horsman, J Arturo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Peptide metabolism; Peptidomics; Prolyl oligopeptidase; Protein convertases

Indexed keywords

BETA ENDORPHIN; CYTOCHROME C OXIDASE; DYNORPHIN A; ENKEPHALIN; GALANIN; HORMONE PRECURSOR; ISOLEUCINE; KYP 2047; MITOCHONDRIAL PROTEIN; NEUROPEPTIDE Y; OCTADECANEUROPEPTIDE; PROLINE; PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR; SECRETONEURIN; SOMATOSTATIN; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME INHIBITION; HYPOTHALAMUS; IN VITRO STUDY; KIDNEY; LIVER; MALE; NONHUMAN; PEPTIDOMICS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN METABOLISM; RAT;

ANIMALS; BRAIN; KIDNEY; LIVER; MALE; MITOCHONDRIA; ORGAN SPECIFICITY; PEPTIDES; PROLINE; PROTEASE INHIBITORS; PROTEOLYSIS; PROTEOME; RATS; RATS, WISTAR; SERINE ENDOPEPTIDASES; TIME FACTORS;

RATTUS;

EID: 84864278794     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.04.005     Document Type: Article

References (38)

1. T.T. Myöhänen, J.I. Venäläinen, J.A. García-Horsman, M. Piltonen, and P.T. Männistö Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues Histochem. Cell. Biol. 130 2008 993 1003
2. T.T. Myöhänen, J.I. Venäläinen, E. Tupala, J.A. García-Horsman, R. Miettinen, and P.T. Männistö Distribution of immunoreactive prolyl oligopeptidase in human and rat brain Neurochem. Res. 32 2007 1365 1374 (Pubitemid 46988198)
3. P.T. Männistö, J. Venäläinen, A. Jalkanen, and J.A. Garcia-Horsman Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders Drug News Perspect. 20 2007 293 305 (Pubitemid 47345221)
4. J.A. García-Horsman, P.T. Männistö, and J.I. Venäläinen On the role of prolyl oligopeptidase in health and disease Neuropeptides 41 2007 1 24 (Pubitemid 46091700)
5. A.M. Lambeir Translational research on prolyl oligopeptidase inhibitors: the long road ahead Expert Opin. Ther. Pat. 21 2011 977 981
6. I. Brandt, K. De Vriendt, B. Devreese, J. Van Beeumen, W. Van Dongen, K. Augustyns, I. De Meester, S. Scharpé, and A.M. Lambeir Search for substrates for prolyl oligopeptidase in porcine brain Peptides 26 2005 2536 2546 (Pubitemid 41676729)
7. W.M. Nolte, D.M. Tagore, W.S. Lane, and A. Saghatelian Peptidomics of prolyl endopeptidase in the central nervous system Biochemistry 48 2009 11971 11981
8. J. Tenorio-Laranga, M.L. Valero, P.T. Männistö, M. Sanchez del Pino, and J.A. Garcia-Horsman Combination of snap freezing, differential pH two-dimensional reverse-phase high-performance liquid chromatography, and iTRAQ technology for the peptidomic analysis of the effect of prolyl oligopeptidase inhibition in the rat brain Anal. Biochem. 393 2009 80 87
9. T. Myöhänen, J. Tenorio-Laranga, B. Jokinen, R. Vazquez-Sanchez, M. Moreno-Baylach, J. Garcia-Horsman, and P. Männistö Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner Br. J. Pharmacol. 163 2011 1666 1678
10. J. Tenorio-Laranga, P.T. Männistö, and J.A. Garcia-Horsman Hunting for peptide substrates of prolyl oligopeptidase: classical versus non-classical bioactive peptides CNS Neurol. Disord. Drug Targets 10 2011 319 326
11. F.Y. Che, and L.D. Fricker Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags J. Mass Spectrom. 40 2005 238 249 (Pubitemid 40327263)
12. H. Pan, F.Y. Che, B. Peng, D.F. Steiner, J.E. Pintar, and L.D. Fricker The role of prohormone convertase-2 in hypothalamic neuropeptide processing: a quantitative neuropeptidomic study J. Neurochem. 98 2006 1763 1777 (Pubitemid 44298243)
13. X. Zhang, F.Y. Che, I. Berezniuk, K. Sonmez, L. Toll, and L.D. Fricker Peptidomics of Cpe(fat/fat) mouse brain regions: implications for neuropeptide processing J. Neurochem. 107 2008 1596 1613
14. D.M. Desiderio Quantitative analytical mass spectrometry of endogenous neuropeptides in human pituitaries Life Sci. 51 1992 169 176
15. K. Skold, M. Svensson, A. Kaplan, L. Bjorkesten, J. Astrom, and P.E. Andren A neuroproteomic approach to targeting neuropeptides in the brain Proteomics 2 2002 447 454 (Pubitemid 34429364)
16. A.J. Jalkanen, T.P. Piepponen, J.J. Hakkarainen, I. De Meester, A.-M. Lambeir, and M.M. Forsberg The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum Neurochem. Int. 60 2012 301 309
17. E.M. Jarho, J.I. Venäläinen, J. Huuskonen, J.A. Christiaans, J.A. Garcia-Horsman, M.M. Forsberg, T. Järvinen, J. Gynther, P.T. Männistö, and E.A. Wallen A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors J. Med. Chem. 47 2004 5605 5607 (Pubitemid 39447255)
18. A.J. Jalkanen, J.J. Hakkarainen, M. Lehtonen, T. Venäläinen, T.M. Kääriäinen, E. Jarho, M. Suhonen, and M.M. Forsberg Brain pharmacokinetics of two prolyl oligopeptidase inhibitors, JTP-4819 and KYP-2047, in the rat Basic Clin. Pharmacol. Toxicol. 109 2011 443 451
19. A.J. Jalkanen, K.A. Puttonen, J.I. Venäläinen, V. Sinerva, A. Mannila, S. Ruotsalainen, E.M. Jarho, E.A. Wallén, and P.T. Männistö Beneficial effect of prolyl oligopeptidase inhibition on spatial memory in young but not in old scopolamine-treated rats Basic Clin. Pharmacol. Toxicol. 100 2007 132 138 (Pubitemid 46146718)
20. A.J. Jalkanen, K. Savolainen, and M.M. Forsberg Inhibition of prolyl oligopeptidase by KYP-2047 fails to increase the extracellular neurotensin and substance P levels in rat striatum Neurosci. Lett. 502 2011 107 111
21. J.I. Venäläinen, J.A. Garcia-Horsman, M.M. Forsberg, A. Jalkanen, E.A. Wallen, E.M. Jarho, J.A. Christiaans, J. Gynther, and P.T. Männistö Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors Biochem. Pharmacol. 71 2006 683 692 (Pubitemid 43122001)
22. N.A. Karp, and K.S. Lilley Investigating sample pooling strategies for DIGE experiments to address biological variability Proteomics 9 2009 388 397
23. G. Dennis Jr., B.T. Sherman, D.A. Hosack, J. Yang, W. Gao, H.C. Lane, and R.A. Lempicki DAVID: Database for Annotation, Visualization, and Integrated Discovery Genome Biol. 4 2003 P3
24. W. Huang da, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 4 2009 44 57
25. F. Al-Shahrour, J. Carbonell, P. Minguez, S. Goetz, A. Conesa, J. Tárraga, I. Medina, E. Alloza, D. Montaner, and J. Dopazo Babelomics: advanced functional profiling of transcriptomics, proteomics and genomics experiments Nucleic Acids Res. 36 2008 W341 W346
26. F. Al-Shahrour, P. Minguez, J. Tárraga, I. Medina, E. Alloza, D. Montaner, and J. Dopazo FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments Nucleic Acids Res. 35 2007 W91 W96
27. J.I. Venäläinen, R.O. Juvonen, M.M. Forsberg, A. Garcia-Horsman, A. Poso, E.A. Wallen, J. Gynther, and P.T. Männistö Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819 Biochem. Pharmacol. 64 2002 463 471 (Pubitemid 34874849)
28. N.G. Seidah What lies ahead for the proprotein convertases? Ann. NY Acad. Sci. 1220 2011 149 161
29. I. Brandt, S. Scharpé, and A.M. Lambeir Suggested functions for prolyl oligopeptidase: a puzzling paradox Clin. Chim. Acta. 377 2007 50 61 (Pubitemid 44914066)
30. K. Toide, T. Fujiwara, Y. Iwamoto, M. Shinoda, K. Okamiya, and T. Kato Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain Naunyn Schmiedebergs Arch. Pharmacol. 353 1996 355 362 (Pubitemid 26092052)
31. K. Toide, K. Okamiya, Y. Iwamoto, and T. Kato Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on prolyl endopeptidase activity and substance P- and arginine-vasopressin-like immunoreactivity in the brains of aged rats J. Neurochem. 65 1995 234 240
32. K. Toide, M. Shinoda, and A. Miyazaki A novel prolyl endopeptidase inhibitor, JTP-4819-its behavioral and neurochemical properties for the treatment of Alzheimer's disease Rev. Neurosci. 9 1998 17 29 (Pubitemid 28334037)
33. M.A. Cavasin, T.D. Liao, X.P. Yang, J.J. Yang, and O.A. Carretero Decreased endogenous levels of Ac-SDKP promote organ fibrosis Hypertension 50 2007 130 136 (Pubitemid 46986021)
34. I. Peltonen, A.J. Jalkanen, V. Sinerva, K.A. Puttonen, and P.T. Männistö Different effects of scopolamine and inhibition of prolyl oligopeptidase on mnemonic and motility functions of young and 8- to 9-month-old rats in the radial-arm maze Basic Clin. Pharmacol. Toxicol. 106 2010 280 287
35. M. Mbikay, N.G. Seidah, and M. Chretien Neuroendocrine secretory protein 7B2: structure, expression and functions Biochem. J. 357 2001 329 342 (Pubitemid 32701769)
36. A.M. Lone, W.M. Nolte, A.D. Tinoco, and A. Saghatelian Peptidomics of the prolyl peptidases AAPS J. 12 2010 483 491
37. A. Brockmann, S.P. Annangudi, T.A. Richmond, S.A. Ament, F. Xie, B.R. Southey, S.R. Rodriguez-Zas, G.E. Robinson, and J.V. Sweedler Quantitative peptidomics reveal brain peptide signatures of behavior Proc. Natl. Acad. Sci. U S A 106 2009 2383 2388
38. M. Svensson, K. Skold, P. Svenningsson, and P.E. Andren Peptidomics-based discovery of novel neuropeptides J. Proteome Res. 2 2003 213 219 (Pubitemid 37099058)